Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor

References

• Gajewski TF, Woo SR, Zha Y, Spaapen R, Zheng Y, Corrales L, Spranger S. Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. Curr Opin Immunol 2013; 25:268-76; PMID:23579075; http://dx.doi.org/10.1016/j.coi.2013.02.009
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Domingos-Pereira S, Duc M, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D. Parenteral but not mucosal immunization is able to induce regression of human papillomavirus associated genital tumors. Int J Cancer 2011; 129:762-72; PMID:21384340; http://dx.doi.org/10.1002/ijc.25973
   PubMed Web of Science ®Google Scholar
• Domingos-Pereira S, Derré L, Warpelin-Decrausaz L, Haefliger JA, Romero P, Jichlinski P, Nardelli-Haefliger D Intravaginal and subcutaneous immunization induced vaccine-specific CD8 T-cells and tumor-regression in the bladder. J Urol. 2014; 191: 814-22.
   Web of Science ®Google Scholar
• Nardelli-Haefliger D, Dudda JC, Romero P. Vaccination route matters for mucosal tumors. Sci Transl Med 2013; 5:172fs4; PMID:23408051; http://dx.doi.org/10.1126/scitranslmed.3005638
   PubMedGoogle Scholar
• Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, Clement O, Marcheteau E, Gey A, Fraisse G, et al. Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors. Sci Transl Med 2013; 5:172ra20; PMID:23408053; http://dx.doi.org/10.1126/scitranslmed.3004888
   PubMed Web of Science ®Google Scholar
• Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012; 491:463-7; PMID:23075848; http://dx.doi.org/10.1038/nature11522
   PubMed Web of Science ®Google Scholar
• Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004; 173:531-41; PMID:15210814; http://dx.doi.org/10.4049/jimmunol.173.1.531
   PubMed Web of Science ®Google Scholar
• Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 2005; 174:992-1002; PMID:15634923; http://dx.doi.org/10.4049/jimmunol.174.2.992
   PubMed Web of Science ®Google Scholar
• Domingos-Pereira S, Decrausaz L, Derre L, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D. Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol 2013; 6:393-404; PMID:22968420; http://dx.doi.org/10.1038/mi.2012.83
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Pythoud C, Domingos-Pereira S, Derré L, Jichlinski P, Nardelli-Haefliger D. Intravaginal live attenuated Salmonella increase local anti-tumor vaccine-specific CD8 T clles. Oncoimmunology 2013; 2:e22944; PMID:23483225
   PubMedGoogle Scholar
• Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66:4-34; PMID:16399414; http://dx.doi.org/10.1016/j.urology.2005.07.062
   PubMed Web of Science ®Google Scholar
• Ellen A, Schenk-Braat M, Bangma CH. Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 2005; 54:414-23; PMID:15565330; http://dx.doi.org/10.1007/s00262-004-0621-x
   PubMedGoogle Scholar
• Herr HW, Morales A. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol 2008; 179:53-6; PMID:17997439; http://dx.doi.org/10.1016/j.juro.2007.08.122
   PubMed Web of Science ®Google Scholar
• Chevalier MF, Nardelli-Haefliger D, Domingos-Pereira S, Jichlinski P, Derre L. Immunotherapeutic strategies for bladder cancer. Hum Vaccin Immunother 2014; 10:977-81; PMID:24384699
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Revaz V, Bobst M, Corthesy B, Romero P, Nardelli-Haefliger D. Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer 2010; 126:2469-78; PMID:19816937
   PubMed Web of Science ®Google Scholar
• Seow SW, Rahmat JN, Bay BH, Lee YK, Mahendran R. Expression of chemokine/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guerin or Lactobacillus rhamnosus strain GG in the healthy murine bladder. Immunology 2008; 124:419-27; PMID:18217952; http://dx.doi.org/10.1111/j.1365-2567.2007.02792.x
   PubMedGoogle Scholar
• Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG, Saban R. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 2001; 5:147-60; PMID:11285368
   PubMed Web of Science ®Google Scholar
• Tengvall S, Lundqvist A, Eisenberg RJ, Cohen GH, Harandi AM. Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes. J Virol 2006; 80:5283-91; PMID:16699008; http://dx.doi.org/10.1128/JVI.02013-05
   PubMed Web of Science ®Google Scholar
• Lindqvist M, Nookaew I, Brinkenberg I, Samuelson E, Thorn K, Nielsen J, Harandi AM. Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems biology. PLoS One 2011; 6:e20448; PMID:21666746; http://dx.doi.org/10.1371/journal.pone.0020448
   PubMedGoogle Scholar
• Rose CE, Jr., Lannigan JA, Kim P, Lee JJ, Fu SM, Sung SS. Murine lung eosinophil activation and chemokine production in allergic airway inflammation. Cell Mol Immunol 2010; 7:361-74; http://dx.doi.org/10.1038/cmi.2010.31
   PubMed Web of Science ®Google Scholar
• Mangsbo SM, Nanalga C, Essand M, Loskog A, Totterman TH. CpG therapy is superior to BCG in an otrhotopic bladder cancer model and generates CD4+ T -cell immunity. J Immunother 2008; 31:34-42; PMID:18157010; http://dx.doi.org/10.1097/CJI.0b013e3181587d29
   PubMed Web of Science ®Google Scholar
• Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol 2005; 23:821-52; PMID:15771587; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115835
   PubMed Web of Science ®Google Scholar
• Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008; 13:2400-7; PMID:17981721; http://dx.doi.org/10.2741/2853
   PubMed Web of Science ®Google Scholar
• Ohtsuka Y, Lee J, Stamm DS, Sanderson IR. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 2001; 49:526-33; PMID:11559650; http://dx.doi.org/10.1136/gut.49.4.526
   PubMed Web of Science ®Google Scholar
• Nataf S, Davoust N, Ames RS, Barnum SR. Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 1999; 162:4018-23; PMID:10201923
   PubMed Web of Science ®Google Scholar
• Liu YJ, Guo DW, Tian L, Shang DS, Zhao WD, Li B, Fang WG, Zhu L, Chen YH. Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent. Neurobiol Aging 2010; 31:175-88; PMID:18462836; http://dx.doi.org/10.1016/j.neurobiolaging.2008.03.024
   PubMedGoogle Scholar
• Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem 1997; 272:11682-5; PMID:9115216; http://dx.doi.org/10.1074/jbc.272.18.11682
   PubMed Web of Science ®Google Scholar
• Luster AD. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-45; PMID:9459648; http://dx.doi.org/10.1056/NEJM199802123380706
   PubMed Web of Science ®Google Scholar
• Ruffing N, Sullivan N, Sharmeen L, Sodroski J, Wu L. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell Immunol 1998; 189:160-8; PMID:9790730; http://dx.doi.org/10.1006/cimm.1998.1379
   PubMed Web of Science ®Google Scholar
• McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 2006; 26:154-8; PMID:16789469
   PubMedGoogle Scholar
• Li Q, Cherayil BJ. Role of Toll-like receptor 4 in macrophage activation and tolerance during Salmonella enterica serovar Typhimurium infection. Infect Immun 2003; 71:4873-82; PMID:12933828; http://dx.doi.org/10.1128/IAI.71.9.4873-4882.2003
   PubMed Web of Science ®Google Scholar
• Mendez-Samperio P, Belmont L, Miranda E. Mycobacterium bovis BCG Toll-like receptors 2 and 4 cooperation increases the innate epithelial immune response. Arch Med Res 2008; 39:33-9; PMID:18067993; http://dx.doi.org/10.1016/j.arcmed.2007.06.019
   PubMedGoogle Scholar
• von Meyenn F, Schaefer M, Weighardt H, Bauer S, Kirschning CJ, Wagner H, Sparwasser T. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guerin by Flt3-ligand generated dendritic cells. Immunobiology 2006; 211:557-65; PMID:16920494; http://dx.doi.org/10.1016/j.imbio.2006.05.004
   PubMedGoogle Scholar
• Magnusson M, Tobes R, Sancho J, Pareja E. Cutting edge: natural DNA repetitive extragenic sequences from gram-negative pathogens strongly stimulate TLR9. J Immunol 2007; 179:31-5; PMID:17579017; http://dx.doi.org/10.4049/jimmunol.179.1.31
   PubMedGoogle Scholar
• Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167:1882-5; PMID:11489966; http://dx.doi.org/10.4049/jimmunol.167.4.1882
   PubMed Web of Science ®Google Scholar
• Honko AN, Mizel SB. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun 2004; 72:6676-9; PMID:15501801; http://dx.doi.org/10.1128/IAI.72.11.6676-6679.2004
   PubMed Web of Science ®Google Scholar
• Hapfelmeier S, Stecher B, Barthel M, Kremer M, Muller AJ, Heikenwalder M, Stallmach T, Hensel M, Pfeffer K, Akira S, et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 2005; 174:1675-85; PMID:15661931; http://dx.doi.org/10.4049/jimmunol.174.3.1675
   PubMed Web of Science ®Google Scholar
• Salamone GV, Petracca Y, Fuxman Bass JI, Rumbo M, Nahmod KA, Gabelloni ML, Vermeulen ME, Matteo MJ, Geffner JR, Trevani AS. Flagellin delays spontaneous human neutrophil apoptosis. Lab Invest 2010; 90:1049-59; PMID:20368700; http://dx.doi.org/10.1038/labinvest.2010.77
   PubMedGoogle Scholar
• Barocas DA, Globe DR, Colayco DC, Onyenwenyi A, Bruno AS, Bramley TJ, Spear RJ. Surveillance and treatment of non-muscle-invasive bladder cancer in the USA. Adv Urol 2012; 2012:421709; PMID:22645607; http://dx.doi.org/10.1155/2012/421709
   PubMedGoogle Scholar
• Begier EM, Burwen DR, Haber P, Ball R, Vaccine Adverse Event Reporting System Working G. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis 2004; 38:771-9; PMID:14999618; http://dx.doi.org/10.1086/381548
   PubMed Web of Science ®Google Scholar
• Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautes-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, et al. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology 2014; 3:e29179; PMID:25083332; http://dx.doi.org/10.4161/onci.29179
   PubMedGoogle Scholar
• Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D. Induction of Human Papillomavirus oncogene-specific CD8 T cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer 2010; 126:2469-78; PMID:19816937
   PubMed Web of Science ®Google Scholar
• Germanier R, Fürer E. Isolation and characterization of galE mutant Ty 21a of Salmonella typhi. A candidate strain for a live, oral typhoid vaccine. J Infect Dis 1975; 131:553-8; PMID:1092768; http://dx.doi.org/10.1093/infdis/131.5.553
   PubMed Web of Science ®Google Scholar
• Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D. Ty21a expressing Human papillomavirus type 16 L1 as a potential live Salmonella vaccine against cervical cancer and typhoid fever. Clin Vaccine Immunol 2007; 14:1285-95; PMID:17687110; http://dx.doi.org/10.1128/CVI.00164-07
   PubMed Web of Science ®Google Scholar
• Revaz V, Debonneville A, Bobst M, Nardelli-Haefliger D. Monitoring of vaccine-specific gamma interferon inductionin in genital mucosa of mice by real-time reverse-transcription-PCR. Clin Vacc Immunol 2008; 5:757-64; PMID:18367582; http://dx.doi.org/10.1128/CVI.00392-07
   PubMedGoogle Scholar
• Lin KY, Guarnieri FG, Staveleyocarroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class ii presentation of tumor antigen. Cancer Res 1996; 56:21-6; PMID:8548765
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Goncalves A-R, Domingos-Pereira S, Pythoud C, Stehle JC, Schiller J, Jichlinski P, Nardelli-Haefliger D. A novel mucosal orthotopic murine model of Human papillomavrius-associated genital cancers. Int J Cancer 2011; 128:2105-13; PMID:20635385; http://dx.doi.org/10.1002/ijc.25561
   PubMed Web of Science ®Google Scholar